You just read:

Vyvanse® (lisdexamfetamine dimesylate) Positive Top-Line Results in Maintenance of Efficacy Study in Adults with Moderate to Severe Binge Eating Disorder

News provided by

Shire plc

Jul 22, 2015, 07:00 ET